Pharmacy news

• Higher Dalbavancin Exposure Linked to Clinical Success in Complicated S. aureus Bacteremia: A Case for a Third Dose?

  11-06-2026 19:12 via pharmacypracticenews.com
  By Gina ShawSome patients with complicated Staphylococcus aureus bacteremia may benefit from a third dose of dalbavancin (Dalvance, AbbVie) beyond the standard two-dose regimen, given either empirically or guided by therapeutic drug monitoring (TDM), said Thomas L. Holland, MD, a professor of medicine in the Division of Infectious Diseases at Duke University, in Durham, North Carolina, in a presentation at the newly combined Making a Difference in Infectious Diseases and Society of Infectious Di
  
  Read more

• New Study Tracks S. aureus Colonization in General Medicine Wards

  11-06-2026 18:39 via pharmacypracticenews.com
  Originally published by our sister publication Infectious Disease Special EditionThis article was updated on 6/5/2026.By Karen BlumStaphylococcus aureus colonization may be common among hospitalized adults in general medical wards, according to a small study presented at ASM Microbe 2026, in Washington, D.C.figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }
  
  Read more

• FDA Approves Enhertu for HER2-Positive Early-Stage Breast Cancer

  11-06-2026 18:35 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy SPC StaffThe FDA approved fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu, Daiichi Sankyo/AstraZeneca) for two HER2-positive early-stage breast cancer indications.figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal;
  
  Read more

• Diversion Software Success Hinges On Trust, Workflow, and Follow-Through

  11-06-2026 18:29 via pharmacypracticenews.com
  By Gina ShawDrug diversion software implementations often stall because of predictable human and workflow challenges that go unaddressed, not technical shortcomings, according to pharmacy leaders at both a small, independent community setting and an academic health system.Thomas Latuga, PharmD, MHA, BCPS, described his hospital’s experience implementing drug diversion software at the ASHP Midyear 2025 Clinical Meeting & Exhibition, in Las Vegas. Dr. Latuga, the director of pharmacy at
  
  Read more

• Advertisement

• ChatGPT Misses the Mark in Complex Cases

  11-06-2026 13:34 via pharmacypracticenews.com
  By Marcus A. BanksThe artificial intelligence tool ChatGPT often misses medication-related problems (MRPs) or flags nonexistent issues, suggesting that AI cannot replace professional judgment or structured training in pharmacy education, according to research presented at the ASHP Midyear 2025 Clinical Meeting & Exhibition, in Las Vegas (poster 4-045).ChatGPT is not adept at spotting drug–drug interactions, noted Stephanie Conway-Allen, PharmD, an associate professor of pharmacy practi
  
  Read more

Follow @newsl_pharmacy on Twitter!